Wed, 27 Feb 2019 13:35:43 GMT
Sarepta to acquire Myonexus in $165M deal
On Wednesday, Sarepta Therapeutics announced it would acquire the privately owned gene therapy firm Myonexus Therapeutics in a deal worth $165M, expanding its footprint in the biotech sector.